Every week, 4000 young women contract HIV. Discover hidden barriers to prevention and innovative solutions that can change ...

CNBC’s Angelica Peebles and Gilead chairman and CEO Daniel O’Day join 'Squawk Box' to discuss the company's new HIV ...

Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...

Among treatment-naive people with HIV, dolutegravir/lamivudine showed viral suppression comparable with those of other ...

By the time doctors began properly treating E.S.’s HIV, “it was super late.” The disease had progressed to AIDS at that point ...

The HSE has launched a campaign to explain advances in HIV treatment and to highlight how delaying going to the doctor is ...

Drought and heavy rainfall also increased the risk of HIV and sexually transmitted infections (STIs), particularly among ...

Kenya has completely run out of essential medical supplies—including HIV medicines, testing kits, and vaccines—putting ...

Mesoblast shares fall ~7% despite a $260 million placement following FDA approval for its cell therapy treatment ...

HIV activist, film maker and podcaster Enda McGrattan, also known as drag queen Veda Lady, shares insights into living with ...

Gilead's chief executive calls lenacapavir a once in a decade medicine. The HIV treatment could push Gilead stock further up ...

The first three times opponents of the Affordable Care Act turned to the U.S. Supreme Court, they failed. Will the fourth ...